Read Our

Equisights Research (“Equisights”) is a distinguished independent sell-side research firm that excels in delivering in-depth, objective analysis and strategic insights. Our research efforts are primarily centered on the U.S. markets, with a strong sectoral emphasis on Technology, Media, and Telecommunications (TMT), healthcare, consumer cyclicals & non-cyclicals, industrials, energy, and select financials. Equisights serves to several notable buy-side funds, RIAs, family offices, and over 1,000 institutional relationships, who take positions across our coverage universe and manage portfolios ranging from $100 million to $1 billion in assets.

Our comprehensive research framework involves an in-depth analysis of each company’s growth potential, financial health, management quality, industry position, risk factors, and valuation. Our recommendations and ratings process is based on gathering and interpreting data, drawing conclusions, and evaluating these factors to determine final ratings based on intrinsic value, expected growth, and risks. Equisights maintains its independence by not participating in public offerings, advising on mergers and acquisitions, brokering trades, making markets in stocks, or managing money.

RESEARCH FEED : OUR PERSPECTIVE

08 Feb, 2025

Fiserv (FI): Clover’s Growth & Embedded Finance at a Crossroads— Assessing the Impact,, Outlook & its 5 Biggest Competitive & Strategic Levers ?

Fiserv closed 2024 on a strong note, delivering 7% reported revenue growth, 13% organic growth, and 180bps of margin expansion to 42.9%, with the merchant segment as the primary driver (+23% organic growth). Clover’s momentum remains robust, posting 29% revenue growth and 14% volume expansion, while VAS penetration scaled to 22%, tracking toward 25% in 2025. Expansion into Brazil, Mexico, and Au... Read More
08 Feb, 2025

Uber Technologies: Expansion of TAM with AV Integration and Fleet Investment —5 Biggest Catalysts Shaping the Future Outlook !

Uber delivered another quarter of accelerating revenue growth and disciplined margin expansion, with Q4 revenue reaching $11.96B, beating estimates by $185M. Adjusted EPS of $3.64 and GAAP EPS of $3.21 exceeded expectations, while gross bookings grew +21% YoY (CC), surpassing Uber’s mid-to-high teens CAGR target. Mobility gross bookings advanced +24% YoY, supported by a U.S. reacceleration, whil... Read More
08 Feb, 2025

Arm Holdings (ARM): AI Agents and DeepSeek Are a Structural Positive—But Can They Clear This One Hurdle? Assessing the Impact, Outlook & its 5 Key Catalysts !

Arm delivered a strong fiscal Q3, with revenue of $983M exceeding guidance and an upbeat Q4 outlook ($1.17B-$1.28B) driven by a large licensing deal and robust royalty growth (+23% YoY). AI-driven adoption of Armv9 and CSS-based chips contributed to record royalty revenue of $580M, though v9 mix has stalled at 25% for three quarters, raising concerns about slower-than-expected migration. Hyperscal... Read More
08 Feb, 2025

SAP SE : The Cloud with a Silver Lining—But Is AI-Driven Growth Built to Last? Assessing Durability, Outlook & Its 5 Key Competitive & Strategic Drivers !

SAP exited 2024 with a record €63.3B cloud backlog (+40% YoY), reinforcing its structural shift to a subscription-based model. Cloud revenue grew 27% YoY, with Cloud ERP expanding 34% YoY to 84% of total cloud sales, driving management’s confidence in sustained double-digit revenue growth through 2027. Installed base migrations remain a core growth pillar, with 60% of Q4 cloud orders stemming ... Read More
08 Feb, 2025

Cigna (CI): Medical Utilization Spikes and Regulatory Overhang—How Much EPS Pressure is Yet to Come for 2025 & Beyond?

Cigna's results signal an inflection point in managed care, with rising medical utilization compressing margins and lowering 2024/25 EPS growth expectations. The company is now in a cost-recovery phase, repricing plans to offset higher claims. Evernorth, however, delivered strong Q4 revenue and earnings growth, driven by specialty businesses and biosimilar adoption. Cigna is de-risking Stop Loss... Read More
08 Feb, 2025

Intuitive Surgical (ISRG): The Robot is Well-Oiled NOW, But Is It Already Priced for Perfection? -What’s the Impact & its 5 Biggest Catalysts Driving the Future Outlook !

Intuitive Surgical closed 2024 with strong momentum, driven by 17% YoY procedure volume growth and a 15% installed base expansion. Revenue reached $8.4B (+17% YoY), with da Vinci 5 placements exceeding expectations. Q4 revenue of $2.41B and adjusted EPS of $2.21 beat estimates, reflecting solid top-line performance and operational leverage. U.S. general surgery and international markets drove g... Read More
08 Feb, 2025

Stryker Corporation (SYK) : Continuing to Outgrow the Market- Inari Acquisition & 4 Key Catalysts Indicating NO Signs of Slowdown!

Stryker delivered a robust Q4 and full-year 2024, exceeding expectations with 10.2% organic sales growth. Strength was broad-based across MedSurg & Neurotechnology and Orthopaedics, driven by strong capital demand and procedural resilience. Mako installations and utilization continue to grow, with upcoming launches for Spine and Shoulder adding further potential. The acquisition of Inari Med... Read More
08 Feb, 2025

Danaher Corporation (DHR): 2025 Growth Pushed Out Amid Soft Guide—Is This a Bump in the Road or a Longer-Term Growth Reset?

Danaher's Q4 performance revealed muted core revenue growth (1%) and adjusted EPS growth (2%), overshadowed by a cautious 2025 outlook that disappointed investors. Despite robust free cash flow and a full-year FCF conversion of 135%, the company anticipates only 3% core revenue growth in 2025, with biotechnology leading at 6-7%, while life sciences and diagnostics lag. Bioprocessing remains a gr... Read More
08 Feb, 2025

Corning Incorporated (GLW): Capitalizing on the Surge in AI Demand — Will Strategic Shifts in Optical and Display Technologies Drive Sustainable Growth?

Corning’s Q4 revenue surged 18% YoY to $3.87B, while operating margins expanded 220bps to 18.5%, reinforcing its path toward exceeding the $3B Springboard revenue target by 2026. Optical Communications remains the core growth engine, with Enterprise sales up 93% YoY in Q4, driven by AI-led hyperscale data center expansion. A two-year deal with Lumen Technologies secures 10% of Corning’s fiber ... Read More
08 Feb, 2025

Charter Communications (CHTR): Capital Peak Resets the Playbook— Will Scale and Convergence Deliver Real Competitive Edge?

Charter exits 2024 at a pivotal transition, balancing broadband stabilization, rising wireless adoption, and peak capital intensity amid sustained competition. Q4 revenue grew 1.6% YoY, with broadband net losses (-177K) primarily driven by the Affordable Connectivity Program (ACP) expiration rather than structural churn. EBITDA expanded nearly 4%, supported by cost discipline, while wireless net a... Read More
Earnings
Market Pulse
Deals
Scroll to Top